Germany Legal Cannabis Market: By Source, By Derivative, By End Use, By City & Segmental Insights Trends and Forecast, 2024 – 2034

  • Industry: Healthcare
  • Report ID: TNR-110-1169
  • Number of Pages: 420
  • Table/Charts : Yes
  • June, 2024
  • Base Year : 2024
  • No. of Companies : 10+
  • No. of Countries : 29
  • Views : 10242
  • Covid Impact Covered: Yes
  • War Impact Covered: Yes
  • Formats : PDF, Excel, PPT

Legal cannabis refers to the cultivation, distribution, possession, and consumption of cannabis products in accordance with established laws and regulations within a specific jurisdiction. The legality of cannabis varies widely across countries and states, with some regions permitting its use for medical purposes, recreational use, or both. In jurisdictions where cannabis is legal, stringent regulatory frameworks govern its production, sale, and consumption to ensure safety, quality control, and compliance with public health standards.

Legalization often involves licensing authorities that oversee cultivation facilities, dispensaries, and retail operations, ensuring adherence to strict guidelines regarding product potency, labelling, and packaging. Legal cannabis markets stimulate economic growth through job creation, tax revenues, and opportunities for entrepreneurship in sectors ranging from agriculture to retail. Furthermore, legalization aims to diminish the illicit cannabis trade, promote consumer safety, and provide access to cannabis for medical patients seeking alternative treatments.

Germany’s aging population and rising prevalence of chronic diseases contribute to the growing demand for alternative therapies that cannabis can potentially address. Moreover, increasing public acceptance and awareness of cannabis’ therapeutic benefits, coupled with ongoing research highlighting its medical efficacy, further fuel demand. Additionally, the economic opportunities presented by the legal cannabis market, including job creation and tax revenues, motivate stakeholders to support its growth, ensuring a robust and expanding market for legal cannabis products in Germany. In terms of revenue, the Germany legal cannabis market was worth US$ 0.8 Bn in 2023, anticipated to witness CAGR of 17.2% during 2024 – 2034.

Germany Legal Cannabis Market Dynamics

Regulatory Framework: Germany’s legalization of medical cannabis in 2017 established a robust regulatory framework overseen by the Federal Institute for Drugs and Medical Devices (BfArM), ensuring controlled cultivation, distribution, and prescription of cannabis products. This clarity has facilitated market growth by providing stakeholders with clear guidelines for compliance and operation.

Growing Patient Demand: Increasing awareness of cannabis’ therapeutic benefits, coupled with a rising incidence of chronic illnesses among Germany’s aging population, has driven patient demand for medical cannabis. Patients seek alternative treatments for conditions such as chronic pain, multiple sclerosis, and epilepsy where conventional therapies have been insufficient.

Healthcare Professional Acceptance: Greater acceptance among healthcare professionals of cannabis as a viable treatment option has led to higher prescription rates. Physicians are increasingly incorporating medical cannabis into treatment plans, contributing to market expansion.

Market Expansion and Investment: The legalization has attracted investments from pharmaceutical companies and entrepreneurs, fostering market growth and innovation in cannabis-based medicines tailored to German healthcare needs.

Marijuana has Gained Popularity in the Recent Years and Has garnered major market share in the Germany Legal Cannabis Market During the Forecast Period (2024 – 2034).

The legalization of medical cannabis in 2017 marked a significant shift in policy, allowing patients with qualifying conditions such as chronic pain, nausea from chemotherapy, and certain neurological disorders to access cannabis-based treatments under medical supervision. This regulatory change has stimulated growth in the medical cannabis market, with an increasing number of patients opting for cannabis as an alternative or complementary therapy.

Secondly, there is a growing acceptance and recognition among healthcare professionals of cannabis’ therapeutic potential, leading to higher prescription rates and patient registrations with the Federal Institute for Drugs and Medical Devices (BfArM). Additionally, Germany’s progressive stance on cannabis research and development has attracted investments from pharmaceutical companies and fostered innovation in cannabis-based medicines. Lastly, public education initiatives and evolving consumer attitudes towards natural and alternative therapies further contribute to the expanding demand for legal cannabis products in Germany.

By Derivative CBD Segment had the Highest Share in the Germany Legal Cannabis Market in 2023.

In Germany, the medical use of CBD (cannabidiol) within the framework of legal cannabis regulations is driven by several significant factors. Firstly, CBD has gained popularity among healthcare professionals and patients for its potential therapeutic benefits, including its anti-inflammatory, analgesic, and anxiolytic properties. The legalization of medical cannabis in 2017 has paved the way for CBD-containing products to be prescribed for various conditions such as chronic pain, anxiety disorders, and epilepsy.

The regulatory clarity provided by Germany’s Federal Institute for Drugs and Medical Devices (BfArM) has facilitated easier access to these treatments, leading to a surge in prescriptions and patient registrations. Furthermore, increasing public awareness and acceptance of CBD’s medical potential, coupled with a growing body of scientific research supporting its efficacy, continue to drive demand. The evolving regulatory landscape and ongoing clinical trials exploring new therapeutic applications of CBD further contribute to the expanding market for medical CBD products in Germany’s healthcare sector.

By End Use Medical Use had the Highest Share in the Germany Legal Cannabis Market in 2023.

In Germany, the medical use of legal cannabis is driven by several key factors. Firstly, there is a growing recognition among healthcare professionals of the therapeutic benefits of cannabis-based medicines in treating various medical conditions, including chronic pain, multiple sclerosis (MS), and certain forms of epilepsy. The legalization and regulation of medical cannabis in 2017 have facilitated broader access to these treatments, prompting an increase in prescriptions and patient registrations with the Federal Institute for Drugs and Medical Devices (BfArM).

Moreover, Germany’s aging population and rising prevalence of chronic illnesses have heightened demand for alternative therapies, where cannabis products offer a promising option for symptom management and improving quality of life. Additionally, patient advocacy groups and medical research continue to support the expansion of approved indications and the development of new cannabis-based medications, further driving the demand for legal medical cannabis in Germany’s healthcare system.

Competitive Landscape:  Germany Legal Cannabis Market:

  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Canopy Growth Corporation
  • Cara Therapeutics Inc.
  • Cronos Group
  • GW Pharmaceuticals, plc
  • Insys Therapeutics, Inc.
  • Sundial Growers Inc.
  • The Scotts Company LLC
  • Tilray
  • VIVO Cannabis Inc.
  • Other Industry Participants

Germany Legal Cannabis Market Scope

Report Specifications Details
Market Revenue in 2023 US$ 0.8 Bn
Market Size Forecast by 2034 US$ 4.6 Bn
Growth Rate (CAGR) 17.2%
Historic Data 2016 – 2022
Base Year for Estimation 2023
Forecast Period 2024 – 2034
Report Inclusions Market Size & Estimates, Market Dynamics, Competitive Scenario, Trends, Growth Factors, Market Determinants, Key Investment Segmentation, Product/Service/Solutions Benchmarking
Segments Covered By Source, By Derivative, By End Use, By City
Cities Covered Berlin, Hamburg, Munich, Koeln, Frankfurt am Main, Rest of Germany
Key Players Aphria, Inc., Aurora Cannabis, Inc., Canopy Growth Corporation, Cara Therapeutics Inc., Cronos Group, GW Pharmaceuticals, plc, Insys Therapeutics, Inc., Sundial Growers Inc., The Scotts Company LLC, Tilray, VIVO Cannabis Inc.
Customization Scope Customization allows for the inclusion/modification of content pertaining to geographical regions, countries, and specific market segments.
Pricing & Procurement Options Explore purchase options tailored to your specific research requirements
Contact Details Consult With Our Expert

Japan (Toll-Free):  +81 663-386-8111

South Korea (Toll-Free):  +82-808- 703-126

Saudi Arabia (Toll-Free):  +966 800-850-1643

United Kingdom: +44 753-710-5080

United States: +1 302-232-5106

E-mail:  askanexpert@thenicheresearch.com

 

Germany Legal Cannabis Market

By Source

  • Marijuana
    • Flowers
    • Oil and Tinctures
  • Hemp
    • Hemp CBD
    • Supplements
    • Industrial Hemp

By Derivative

  • CBD
  • THC
  • Others

By End Use

  • Medical Use
    • Cancer
    • Chronic Pain
    • Depression and Anxiety
    • Arthritis
    • Diabetes
    • Glaucoma
    • Migraines
    • Epilepsy
    • Multiple Sclerosis
    • AIDS
    • Amyotrophic Lateral Sclerosis
    • Alzheimer’s
    • Post-Traumatic Stress Disorder (PTSD)
    • Parkinson’s
    • Tourette’s
    • Others
  • Recreational Use
  • Industrial Use

By City

  • Berlin
  • Hamburg
  • Munich
  • Koeln
  • Frankfurt am Main
  • Rest of Germany

 Report Layout:

Table of Contents

.

1.Market Scope
1.1.Market Segmentation
1.2.Years Considered
1.2.1.Historic Years: 2017 – 2022
1.2.2.Base Year: 2023
1.2.3.Forecast Years: 2024 – 2034
2.Key Target Audiences
3.Research Methodology
3.1.Primary Research
3.1.1.Research Questionnaire
3.1.2.Germany Percentage Breakdown
3.1.3.Primary Interviews: Key Opinion Leaders (KOLs)
3.2.Secondary Research
3.2.1.Paid Databases
3.2.2.Secondary Sources
3.3.Market Size Estimates
3.3.1.Top-Down Approach
3.3.2.Bottom-Up Approach
3.4.Data Triangulation Methodology
3.5.Research Assumptions
4.Recommendations and Insights from TNR’s Perspective**
5.Holistic Overview of Legal Cannabis Market
6.Market Synopsis: Legal Cannabis Market
7.Legal Cannabis Market Analysis: Qualitative Perspective
7.1.Introduction
7.1.1.Product Definition
7.1.2.Industry Development
7.2.Market Dynamics
7.2.1.Drivers
7.2.2.Restraints
7.2.3.Opportunities
7.2.4.Challenges
7.3.Trends in Legal Cannabis Market
7.4.Market Determinants Radar Chart
7.5.Macro-Economic and Micro-Economic Indicators: Legal Cannabis Market
7.6.Industry Gross Margin Overview
7.7.Porter’s Five Force Analysis
7.8.Impact of Covid-19 on Legal Cannabis Market
7.9.PESTEL Analysis
7.10.Value Chain Analysis
7.11.Pricing Analysis, By City (2023)
7.11.1.Berlin
7.11.2.Hamburg
7.11.3.Munich
7.11.4.Koeln
7.11.5.Frankfurt am Main
7.11.6.Rest of Germany
8.Germany Legal Cannabis Market Analysis and Forecasts, 2024 – 2034
8.1.Overview
8.1.1.Germany Legal Cannabis Market Revenue (US$ Mn)
8.2.Germany Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Source
8.2.1.Marijuana (Definition, Market Penetration (2023), Market Estimation (2017 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (Berlin, Hamburg, Munich, Koeln, Frankfurt am Main, Rest of Germany) and Information on Flowers, Oil and Tinctures)
8.2.1.1.Flowers
8.2.1.2.Oil and Tinctures
8.2.2.Hemp (Definition, Market Penetration (2023), Market Estimation (2017 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (Berlin, Hamburg, Munich, Koeln, Frankfurt am Main, Rest of Germany) and Information on Hemp CBD, Supplements, Industrial Hemp)
8.2.2.1.Hemp CBD
8.2.2.2.Supplements
8.2.2.3.Industrial Hemp
8.3.Key Segment for Channeling Investments
8.3.1.By Source
9.Germany Legal Cannabis Market Analysis and Forecasts, 2024 – 2034
9.1.Overview
9.2.Germany Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Derivative
9.2.1.CBD
9.2.1.1.Definition
9.2.1.2.Market Estimation and Penetration, 2017 – 2023
9.2.1.3.Market Forecast, 2024 – 2034
9.2.1.4.Compound Annual Growth Rate (CAGR)
9.2.1.5.Regional Bifurcation
9.2.1.5.1.Berlin
9.2.1.5.1.1.Market Estimation, 2017 – 2023
9.2.1.5.1.2.Market Forecast, 2024 – 2034
9.2.1.5.2.Hamburg
9.2.1.5.2.1.Market Estimation, 2017 – 2023
9.2.1.5.2.2.Market Forecast, 2024 – 2034
9.2.1.5.3.Munich
9.2.1.5.3.1.Market Estimation, 2017 – 2023
9.2.1.5.3.2.Market Forecast, 2024 – 2034
9.2.1.5.4.Koeln
9.2.1.5.4.1.Market Estimation, 2017 – 2023
9.2.1.5.4.2.Market Forecast, 2024 – 2034
9.2.1.5.5.Frankfurt am Main
9.2.1.5.5.1.Market Estimation, 2017 – 2023
9.2.1.5.5.2.Market Forecast, 2024 – 2034
9.2.1.5.6.Rest of Germany
9.2.1.5.6.1.Market Estimation, 2017 – 2023
9.2.1.5.6.2.Market Forecast, 2024 – 2034
9.2.2.THC
9.2.2.1.Definition
9.2.2.2.Market Estimation and Penetration, 2017 – 2023
9.2.2.3.Market Forecast, 2024 – 2034
9.2.2.4.Compound Annual Growth Rate (CAGR)
9.2.2.5.Regional Bifurcation
9.2.2.5.1.Berlin
9.2.2.5.1.1.Market Estimation, 2017 – 2023
9.2.2.5.1.2.Market Forecast, 2024 – 2034
9.2.2.5.2.Hamburg
9.2.2.5.2.1.Market Estimation, 2017 – 2023
9.2.2.5.2.2.Market Forecast, 2024 – 2034
9.2.2.5.3.Munich
9.2.2.5.3.1.Market Estimation, 2017 – 2023
9.2.2.5.3.2.Market Forecast, 2024 – 2034
9.2.2.5.4.Koeln
9.2.2.5.4.1.Market Estimation, 2017 – 2023
9.2.2.5.4.2.Market Forecast, 2024 – 2034
9.2.2.5.5.Frankfurt am Main
9.2.2.5.5.1.Market Estimation, 2017 – 2023
9.2.2.5.5.2.Market Forecast, 2024 – 2034
9.2.2.5.6.Rest of Germany
9.2.2.5.6.1.Market Estimation, 2017 – 2023
9.2.2.5.6.2.Market Forecast, 2024 – 2034
9.2.3.Others
9.2.3.1.Definition
9.2.3.2.Market Estimation and Penetration, 2017 – 2023
9.2.3.3.Market Forecast, 2024 – 2034
9.2.3.4.Compound Annual Growth Rate (CAGR)
9.2.3.5.Regional Bifurcation
9.2.3.5.1.Berlin
9.2.3.5.1.1.Market Estimation, 2017 – 2023
9.2.3.5.1.2.Market Forecast, 2024 – 2034
9.2.3.5.2.Hamburg
9.2.3.5.2.1.Market Estimation, 2017 – 2023
9.2.3.5.2.2.Market Forecast, 2024 – 2034
9.2.3.5.3.Munich
9.2.3.5.3.1.Market Estimation, 2017 – 2023
9.2.3.5.3.2.Market Forecast, 2024 – 2034
9.2.3.5.4.Koeln
9.2.3.5.4.1.Market Estimation, 2017 – 2023
9.2.3.5.4.2.Market Forecast, 2024 – 2034
9.2.3.5.5.Frankfurt am Main
9.2.3.5.5.1.Market Estimation, 2017 – 2023
9.2.3.5.5.2.Market Forecast, 2024 – 2034
9.2.3.5.6.Rest of Germany
9.2.3.5.6.1.Market Estimation, 2017 – 2023
9.2.3.5.6.2.Market Forecast, 2024 – 2034
9.3.Key Segment for Channeling Investments
9.3.1.By Derivative
10.Germany Legal Cannabis Market Analysis and Forecasts, 2024 – 2034
10.1.Overview
10.2.Germany Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By End Use
10.2.1.Medical Use (Definition, Market Penetration (2023), Market Estimation (2017 – 2023), Market Forecast (2024 – 2034), Compound Annual Growth Rate (CAGR), Regional Bifurcation (Berlin, Hamburg, Munich, Koeln, Frankfurt am Main, Rest of Germany) and Information on Cancer, Chronic Pain, Depression and Anxiety, Arthritis, Diabetes, Glaucoma, Migraines, Epilepsy, Multiple Sclerosis, AIDS, Amyotrophic Lateral Sclerosis, Alzheimer’s, Post-Traumatic Stress Disorder (PTSD), Parkinson’s, Tourette’s, Others)
10.2.1.1.Cancer
10.2.1.2.Chronic Pain
10.2.1.3.Depression and Anxiety
10.2.1.4.Arthritis
10.2.1.5.Diabetes
10.2.1.6.Glaucoma
10.2.1.7.Migraines
10.2.1.8.Epilepsy
10.2.1.9.Multiple Sclerosis
10.2.1.10.AIDS
10.2.1.11.Amyotrophic Lateral Sclerosis
10.2.1.12.Alzheimer’s
10.2.1.13.Post-Traumatic Stress Disorder (PTSD)
10.2.1.14.Parkinson’s
10.2.1.15.Tourette’s
10.2.1.16.Others
10.2.2.Recreational Use
10.2.2.1.Definition
10.2.2.2.Market Estimation and Penetration, 2017 – 2023
10.2.2.3.Market Forecast, 2024 – 2034
10.2.2.4.Compound Annual Growth Rate (CAGR)
10.2.2.5.Regional Bifurcation
10.2.2.5.1.Berlin
10.2.2.5.1.1.Market Estimation, 2017 – 2023
10.2.2.5.1.2.Market Forecast, 2024 – 2034
10.2.2.5.2.Hamburg
10.2.2.5.2.1.Market Estimation, 2017 – 2023
10.2.2.5.2.2.Market Forecast, 2024 – 2034
10.2.2.5.3.Munich
10.2.2.5.3.1.Market Estimation, 2017 – 2023
10.2.2.5.3.2.Market Forecast, 2024 – 2034
10.2.2.5.4.Koeln
10.2.2.5.4.1.Market Estimation, 2017 – 2023
10.2.2.5.4.2.Market Forecast, 2024 – 2034
10.2.2.5.5.Frankfurt am Main
10.2.2.5.5.1.Market Estimation, 2017 – 2023
10.2.2.5.5.2.Market Forecast, 2024 – 2034
10.2.2.5.6.Rest of Germany
10.2.2.5.6.1.Market Estimation, 2017 – 2023
10.2.2.5.6.2.Market Forecast, 2024 – 2034
10.2.3.Industrial Use
10.2.3.1.Definition
10.2.3.2.Market Estimation and Penetration, 2017 – 2023
10.2.3.3.Market Forecast, 2024 – 2034
10.2.3.4.Compound Annual Growth Rate (CAGR)
10.2.3.5.Regional Bifurcation
10.2.3.5.1.Berlin
10.2.3.5.1.1.Market Estimation, 2017 – 2023
10.2.3.5.1.2.Market Forecast, 2024 – 2034
10.2.3.5.2.Hamburg
10.2.3.5.2.1.Market Estimation, 2017 – 2023
10.2.3.5.2.2.Market Forecast, 2024 – 2034
10.2.3.5.3.Munich
10.2.3.5.3.1.Market Estimation, 2017 – 2023
10.2.3.5.3.2.Market Forecast, 2024 – 2034
10.2.3.5.4.Koeln
10.2.3.5.4.1.Market Estimation, 2017 – 2023
10.2.3.5.4.2.Market Forecast, 2024 – 2034
10.2.3.5.5.Frankfurt am Main
10.2.3.5.5.1.Market Estimation, 2017 – 2023
10.2.3.5.5.2.Market Forecast, 2024 – 2034
10.2.3.5.6.Rest of Germany
10.2.3.5.6.1.Market Estimation, 2017 – 2023
10.2.3.5.6.2.Market Forecast, 2024 – 2034
10.3.Key Segment for Channeling Investments
10.3.1.By End Use
11.Germany Legal Cannabis Market Analysis and Forecasts, 2024 – 2034
11.1.Overview
11.2.Germany Legal Cannabis Market Revenue (US$ Mn) and Forecasts By City
11.2.1.Berlin
11.2.1.1.Berlin Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Source
11.2.1.1.1.Marijuana
11.2.1.1.1.1.Flowers
11.2.1.1.1.2.Oil and Tinctures
11.2.1.1.2.Hemp
11.2.1.1.2.1.Hemp CBD
11.2.1.1.2.2.Supplements
11.2.1.1.2.3.Industrial Hemp
11.2.1.2.Berlin Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Derivative
11.2.1.2.1.CBD
11.2.1.2.2.THC
11.2.1.2.3.Others
11.2.1.3.Berlin Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By End Use
11.2.1.3.1.Medical Use
11.2.1.3.1.1.Cancer
11.2.1.3.1.2.Chronic Pain
11.2.1.3.1.3.Depression and Anxiety
11.2.1.3.1.4.Arthritis
11.2.1.3.1.5.Diabetes
11.2.1.3.1.6.Glaucoma
11.2.1.3.1.7.Migraines
11.2.1.3.1.8.Epilepsy
11.2.1.3.1.9.Multiple Sclerosis
11.2.1.3.1.10.AIDS
11.2.1.3.1.11.Amyotrophic Lateral Sclerosis
11.2.1.3.1.12.Alzheimer’s
11.2.1.3.1.13.Post-Traumatic Stress Disorder (PTSD)
11.2.1.3.1.14.Parkinson’s
11.2.1.3.1.15.Tourette’s
11.2.1.3.1.16.Others
11.2.1.3.2.Recreational Use
11.2.1.3.3.Industrial Use
11.2.2.Hamburg
11.2.2.1.Hamburg Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Source
11.2.2.1.1.Marijuana
11.2.2.1.1.1.Flowers
11.2.2.1.1.2.Oil and Tinctures
11.2.2.1.2.Hemp
11.2.2.1.2.1.Hemp CBD
11.2.2.1.2.2.Supplements
11.2.2.1.2.3.Industrial Hemp
11.2.2.2.Hamburg Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Derivative
11.2.2.2.1.CBD
11.2.2.2.2.THC
11.2.2.2.3.Others
11.2.2.3.Hamburg Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By End Use
11.2.2.3.1.Medical Use
11.2.2.3.1.1.Cancer
11.2.2.3.1.2.Chronic Pain
11.2.2.3.1.3.Depression and Anxiety
11.2.2.3.1.4.Arthritis
11.2.2.3.1.5.Diabetes
11.2.2.3.1.6.Glaucoma
11.2.2.3.1.7.Migraines
11.2.2.3.1.8.Epilepsy
11.2.2.3.1.9.Multiple Sclerosis
11.2.2.3.1.10.AIDS
11.2.2.3.1.11.Amyotrophic Lateral Sclerosis
11.2.2.3.1.12.Alzheimer’s
11.2.2.3.1.13.Post-Traumatic Stress Disorder (PTSD)
11.2.2.3.1.14.Parkinson’s
11.2.2.3.1.15.Tourette’s
11.2.2.3.1.16.Others
11.2.2.3.2.Recreational Use
11.2.2.3.3.Industrial Use
11.2.3.Munich
11.2.3.1.Munich Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Source
11.2.3.1.1.Marijuana
11.2.3.1.1.1.Flowers
11.2.3.1.1.2.Oil and Tinctures
11.2.3.1.2.Hemp
11.2.3.1.2.1.Hemp CBD
11.2.3.1.2.2.Supplements
11.2.3.1.2.3.Industrial Hemp
11.2.3.2.Munich Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Derivative
11.2.3.2.1.CBD
11.2.3.2.2.THC
11.2.3.2.3.Others
11.2.3.3.Munich Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By End Use
11.2.3.3.1.Medical Use
11.2.3.3.1.1.Cancer
11.2.3.3.1.2.Chronic Pain
11.2.3.3.1.3.Depression and Anxiety
11.2.3.3.1.4.Arthritis
11.2.3.3.1.5.Diabetes
11.2.3.3.1.6.Glaucoma
11.2.3.3.1.7.Migraines
11.2.3.3.1.8.Epilepsy
11.2.3.3.1.9.Multiple Sclerosis
11.2.3.3.1.10.AIDS
11.2.3.3.1.11.Amyotrophic Lateral Sclerosis
11.2.3.3.1.12.Alzheimer’s
11.2.3.3.1.13.Post-Traumatic Stress Disorder (PTSD)
11.2.3.3.1.14.Parkinson’s
11.2.3.3.1.15.Tourette’s
11.2.3.3.1.16.Others
11.2.3.3.2.Recreational Use
11.2.3.3.3.Industrial Use
11.2.4.Koeln
11.2.4.1.Koeln Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Source
11.2.4.1.1.Marijuana
11.2.4.1.1.1.Flowers
11.2.4.1.1.2.Oil and Tinctures
11.2.4.1.2.Hemp
11.2.4.1.2.1.Hemp CBD
11.2.4.1.2.2.Supplements
11.2.4.1.2.3.Industrial Hemp
11.2.4.2.Koeln Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Derivative
11.2.4.2.1.CBD
11.2.4.2.2.THC
11.2.4.2.3.Others
11.2.4.3.Koeln Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By End Use
11.2.4.3.1.Medical Use
11.2.4.3.1.1.Cancer
11.2.4.3.1.2.Chronic Pain
11.2.4.3.1.3.Depression and Anxiety
11.2.4.3.1.4.Arthritis
11.2.4.3.1.5.Diabetes
11.2.4.3.1.6.Glaucoma
11.2.4.3.1.7.Migraines
11.2.4.3.1.8.Epilepsy
11.2.4.3.1.9.Multiple Sclerosis
11.2.4.3.1.10.AIDS
11.2.4.3.1.11.Amyotrophic Lateral Sclerosis
11.2.4.3.1.12.Alzheimer’s
11.2.4.3.1.13.Post-Traumatic Stress Disorder (PTSD)
11.2.4.3.1.14.Parkinson’s
11.2.4.3.1.15.Tourette’s
11.2.4.3.1.16.Others
11.2.4.3.2.Recreational Use
11.2.4.3.3.Industrial Use
11.2.5.Frankfurt am Main
11.2.5.1.Frankfurt am Main Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Source
11.2.5.1.1.Marijuana
11.2.5.1.1.1.Flowers
11.2.5.1.1.2.Oil and Tinctures
11.2.5.1.2.Hemp
11.2.5.1.2.1.Hemp CBD
11.2.5.1.2.2.Supplements
11.2.5.1.2.3.Industrial Hemp
11.2.5.2.Frankfurt am Main Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Derivative
11.2.5.2.1.CBD
11.2.5.2.2.THC
11.2.5.2.3.Others
11.2.5.3.Frankfurt am Main Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By End Use
11.2.5.3.1.Medical Use
11.2.5.3.1.1.Cancer
11.2.5.3.1.2.Chronic Pain
11.2.5.3.1.3.Depression and Anxiety
11.2.5.3.1.4.Arthritis
11.2.5.3.1.5.Diabetes
11.2.5.3.1.6.Glaucoma
11.2.5.3.1.7.Migraines
11.2.5.3.1.8.Epilepsy
11.2.5.3.1.9.Multiple Sclerosis
11.2.5.3.1.10.AIDS
11.2.5.3.1.11.Amyotrophic Lateral Sclerosis
11.2.5.3.1.12.Alzheimer’s
11.2.5.3.1.13.Post-Traumatic Stress Disorder (PTSD)
11.2.5.3.1.14.Parkinson’s
11.2.5.3.1.15.Tourette’s
11.2.5.3.1.16.Others
11.2.5.3.2.Recreational Use
11.2.5.3.3.Industrial Use
11.2.6.Rest of Germany
11.2.6.1.Rest of Germany Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Source
11.2.6.1.1.Marijuana
11.2.6.1.1.1.Flowers
11.2.6.1.1.2.Oil and Tinctures
11.2.6.1.2.Hemp
11.2.6.1.2.1.Hemp CBD
11.2.6.1.2.2.Supplements
11.2.6.1.2.3.Industrial Hemp
11.2.6.2.Rest of Germany Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By Derivative
11.2.6.2.1.CBD
11.2.6.2.2.THC
11.2.6.2.3.Others
11.2.6.3.Rest of Germany Legal Cannabis Market Revenue (US$ Mn) and Forecasts, By End Use
11.2.6.3.1.Medical Use
11.2.6.3.1.1.Cancer
11.2.6.3.1.2.Chronic Pain
11.2.6.3.1.3.Depression and Anxiety
11.2.6.3.1.4.Arthritis
11.2.6.3.1.5.Diabetes
11.2.6.3.1.6.Glaucoma
11.2.6.3.1.7.Migraines
11.2.6.3.1.8.Epilepsy
11.2.6.3.1.9.Multiple Sclerosis
11.2.6.3.1.10.AIDS
11.2.6.3.1.11.Amyotrophic Lateral Sclerosis
11.2.6.3.1.12.Alzheimer’s
11.2.6.3.1.13.Post-Traumatic Stress Disorder (PTSD)
11.2.6.3.1.14.Parkinson’s
11.2.6.3.1.15.Tourette’s
11.2.6.3.1.16.Others
11.2.6.3.2.Recreational Use
11.2.6.3.3.Industrial Use
12.Competitive Benchmarking
12.1.Brand Benchmarking
12.2.Market Share Analysis, 2023
12.3.Germany Presence and Growth Strategies
12.3.1.Mergers and Acquisitions
12.3.2.Product Launches
12.3.3.Investments Trends
12.3.4.R&D Initiatives
13.Player Profiles
13.1.Aphria, Inc.
13.1.1.Company Details
13.1.2.Company Overview
13.1.3.Product Offerings
13.1.4.Key Developments
13.1.5.Financial Analysis
13.1.6.SWOT Analysis
13.1.7.Business Strategies
13.2.Aurora Cannabis, Inc.
13.2.1.Company Details
13.2.2.Company Overview
13.2.3.Product Offerings
13.2.4.Key Developments
13.2.5.Financial Analysis
13.2.6.SWOT Analysis
13.2.7.Business Strategies
13.3.Canopy Growth Corporation
13.3.1.Company Details
13.3.2.Company Overview
13.3.3.Product Offerings
13.3.4.Key Developments
13.3.5.Financial Analysis
13.3.6.SWOT Analysis
13.3.7.Business Strategies
13.4.Cara Therapeutics Inc.
13.4.1.Company Details
13.4.2.Company Overview
13.4.3.Product Offerings
13.4.4.Key Developments
13.4.5.Financial Analysis
13.4.6.SWOT Analysis
13.4.7.Business Strategies
13.5.Cronos Group
13.5.1.Company Details
13.5.2.Company Overview
13.5.3.Product Offerings
13.5.4.Key Developments
13.5.5.Financial Analysis
13.5.6.SWOT Analysis
13.5.7.Business Strategies
13.6.GW Pharmaceuticals, plc
13.6.1.Company Details
13.6.2.Company Overview
13.6.3.Product Offerings
13.6.4.Key Developments
13.6.5.Financial Analysis
13.6.6.SWOT Analysis
13.6.7.Business Strategies
13.7.Insys Therapeutics, Inc.
13.7.1.Company Details
13.7.2.Company Overview
13.7.3.Product Offerings
13.7.4.Key Developments
13.7.5.Financial Analysis
13.7.6.SWOT Analysis
13.7.7.Business Strategies
13.8.Sundial Growers Inc.
13.8.1.Company Details
13.8.2.Company Overview
13.8.3.Product Offerings
13.8.4.Key Developments
13.8.5.Financial Analysis
13.8.6.SWOT Analysis
13.8.7.Business Strategies
13.9.The Scotts Company LLC
13.9.1.Company Details
13.9.2.Company Overview
13.9.3.Product Offerings
13.9.4.Key Developments
13.9.5.Financial Analysis
13.9.6.SWOT Analysis
13.9.7.Business Strategies
13.10.Tilray
13.10.1.Company Details
13.10.2.Company Overview
13.10.3.Product Offerings
13.10.4.Key Developments
13.10.5.Financial Analysis
13.10.6.SWOT Analysis
13.10.7.Business Strategies
13.11.VIVO Cannabis Inc.
13.11.1.Company Details
13.11.2.Company Overview
13.11.3.Product Offerings
13.11.4.Key Developments
13.11.5.Financial Analysis
13.11.6.SWOT Analysis
13.11.7.Business Strategies
13.12.Other Industry Participants
14.Key Findings

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

.

**Exclusive for Multi-User and Enterprise User.

Germany Legal Cannabis Market

By Source

  • Marijuana
    • Flowers
    • Oil and Tinctures
  • Hemp
    • Hemp CBD
    • Supplements
    • Industrial Hemp

By Derivative

  • CBD
  • THC
  • Others

By End Use

  • Medical Use
    • Cancer
    • Chronic Pain
    • Depression and Anxiety
    • Arthritis
    • Diabetes
    • Glaucoma
    • Migraines
    • Epilepsy
    • Multiple Sclerosis
    • AIDS
    • Amyotrophic Lateral Sclerosis
    • Alzheimer’s
    • Post-Traumatic Stress Disorder (PTSD)
    • Parkinson’s
    • Tourette’s
    • Others
  • Recreational Use
  • Industrial Use

By City

  • Berlin
  • Hamburg
  • Munich
  • Koeln
  • Frankfurt am Main
  • Rest of Germany

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

  • Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
  • Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
  • Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
  • In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

  • Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
  • Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
  • Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
  • Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
  • New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
  • Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
  • End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
  • Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
  • Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.

 

 

Procure Comprehensive Study of

Germany Legal Cannabis Market

Online Only

  • Online Access
  • Read Only File
  • Validity 3 Months
  • Print, Copy, Paste & Download
  • PPT, Excel
  • Cost-Free Report in the Next Update
$3300
Buy Now

Single User

  • Access to One User on One System
  • Read Only File
  • Validity 6 Months
  • Limited Print,Copy, Paste
  • PPT, Excel
  • Cost-Free Report in the Next Update
$4200
Buy Now

Multi User

  • Access to Fiver Users
  • PDF File
  • Validity 1 Year
  • Upto FivePrints
  • Cost-Free Report in the Next Update
  • PPT, Excel
$6000
Buy Now

Enterprise User

  • Access to Unlimited Users
  • PDF, PPT, Excel
  • Unlimited Validity, Prints&Downloads
  • 1 Hour Cost-Free & Dedicated Analyst Support
  • 10% Cost-Free Customization
  • Cost-Free Report Update Twice in a Year
  • Recommendations for Business Strategies
  • Authorization to Quote TNR, The Niche Research
$7300
Buy Now

Library Access

  • Online Access to Content Publications
  • Access Player Profiles Online
  • Get Immediate Access to Newly Added Content
  • Acquire 12 PDF Downloads
  • Acquire 5 Excel Data Sets
  • Gain Access to 290+ PDFs of Company Profiles
  • Round-the-clock Email and Phone Assistance
  • Dashboard Usage and Trends
  • Renewal & Upgrade Assistance
  • Assessing Customization Options and Alerts for New Reports
$10788
Buy Now
*Taxes/Fees, if applicable will be added during checkout. All prices in USD

Why TNR The Niche Research?

  • Unwavering Commitment to Excellence

  • Veteran Team of Researchers

  • Accurate and Timely Insights

  • Ethical Practices and Customized Service

  • Uninterrupted Availability Around the Clock

Scroll to Top